Rapid-Fire Roundtable on Melanoma: Focus on Advances in Adjuvant Treatment, Neoadjuvant Treatment, and Management of Metastatic Disease

Author(s)/Faculty: Jeffrey S. Weber, MD, PhD; Tara C. Mitchell, MD; Hussein A. Tawbi, MD, PhD
Release Date: 12/22/2021Expiration Date: 12/21/2022
Credit Type: CMENumber of Credits: 0.75
Content Type: LectureProvider:
Treatment for patients with advanced melanoma has been revolutionized through the integration of immune checkpoint inhibitors (CPI) and targeted therapy into management algorithms. With these advances, new challenges have emerged, including identifying the patients who will benefit most from adjuvant and neoadjuvant approaches. In this Rapid-Fire Roundtable educational activity, experts in the field discuss clinical advances pertaining to CPI-based therapy—evaluating patient and tumor characteristics that may inform treatment selection. Faculty will engage in a fast-paced review of the latest data on adjuvant and neoadjuvant regimens as well as emerging options for recurrent melanoma, providing key pearls on immunotherapy to guide clinical decision-making.